⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3900672 | 0.74 | — | — | |
| SCHEMBL3899974 | 0.74 | — | — | |
| SCHEMBL3310184 | 0.74 | — | — | |
| SCHEMBL1933577 | 0.73 | BRD4 (0.33) | — | |
| SCHEMBL1933580 | 0.73 | BRD4 (0.33) | — | |
| SCHEMBL1934068 | 0.73 | BRD4 (0.33) | — | |
| SCHEMBL1934066 | 0.73 | BRD4 (0.33) | — | |
| SCHEMBL1934262 | 0.73 | BRD4 (0.33) | — | |
| SCHEMBL10964532 | 0.73 | MEN1 (0.41) | — | |
| SCHEMBL3136461 | 0.69 | MEN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113784721-B | High activity compounds against COVID-19 | 阿堤亚制药公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119139338-A | High activity compounds against COVID-19 | 阿堤亚制药公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118948877-A | High activity compounds against COVID-19 | 阿堤亚制药公司 | 2024-11-15 | — | — | CN | disclosed |
| US-11738038-B2 | Highly active compounds against COVID-19 | Atea Pharmaceuticals, Inc. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20220347200-A1 | HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 | Atea Pharmaceuticals, Inc. (US) | 2022-11-03 | — | — | US | disclosed |
| CN-113784721-A | High activity compound for resisting COVID-19 | 阿堤亚制药公司 | 2021-12-10 | — | — | CN | disclosed |
| EP-3897668-A1 | HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 | ATEA Pharmaceuticals, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |